Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1

PF-07081532 is the first clinical candidate from multi-target drug discovery collaboration to advance into Phase 2 trialsDosing of first subject in Phase 2...

Related Keywords

Japan ,Tokyo ,Cambridge ,Cambridgeshire ,United Kingdom ,Eleanor Perkin ,Frazer Hall ,Neurocrine Biosciences ,Sosei Heptares ,Hironoshin Nomura ,Candelle Chong ,Matt Barnes ,Genentech Roche ,Shinichiro Nishishita ,Sosei Group Corporation ,Linkedin ,Twitter ,Novartis ,Pfizer ,Astrazeneca ,Youtube ,Sosei Group ,Sosei Group Corporation The Company ,Tokyo Stock Exchange ,Medistrava Consulting For International Media ,Group Corporation ,Inflammatory Bowel Disease ,Chief Financial Officer ,International Media ,Japan Exchange Group 4565 T ,Biotech ,Biotechnology ,Pcr ,Diabetes ,Obesity ,Collaboration ,